Stansberry Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Stansberry Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-168,629	Closed	-$16.4M	–	55
2019 Q3	$16.4M	Buy	168,629 +1,024	+0.6%	+$103K	7.23%	3
2019 Q2	$17.2M	Buy	+167,605	New	+$18.1M	6.76%	3

Stansberry Asset Management's ONCE Position: Q4 2019 in Review

Stansberry Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 168,629 shares — an estimated $16.4M sold.

Stansberry Asset Management first reported a position in ONCE in Q2 2019 and held it in 2 quarters. The position peaked at $17.2M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Stansberry Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Stansberry Asset Management sold 168,629 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $16.4M.
Stansberry Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
Stansberry Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $17.2M in Q2 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Stansberry Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.